ONYX PHARMACEUTICALS INC: cashflow_operating

Value{"amount": -129486000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"}
Period2012-01-01 – 2012-09-30
Statuscurrent
EntityONYX PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-12-073762 · Open the official SEC filing →
Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001012140/cashflow-operating/2012-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/bed9f192-5f9f-4fae-b618-17d52224ce14

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies